National Multiple Sclerosis Society Creates Program to Translate Research to Therapies

Timothy Coetzee, executive director of the new program, describes how the NMSS intends to bridge the gap between university research and commercial drug development in order to speed the commercialization of new treatments for MS.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.